The stockmarket melt-up just keeps going
Despite all the bad news, markets just keep hitting new highs. Should you be worried?


Levels of public debt not seen since World War II; a labour shortage; fast-rising inflation; more new Covid-19 variants; small businesses suffering from supply crunches; chaos in Afghanistan; rising mutterings about inequality; anti-wealth and anti-market policies in China; ridiculously high equity valuations in the US. It’s a lot for markets to cope with. You’d think they’d wobble some, but no. Instead, the melt-up just keeps going – and America’s S&P 500 index just keeps hitting record highs. Should you worry?
There are stories you can tell to make yourself feel a bit better (stockmarkets are nothing more than a sum of stories). You could perhaps argue that US earnings estimates are rising so fast that it makes everything look kind of OK. S&P 500 stocks as a whole beat analysts’ estimates nicely in both the first and second quarters – so everyone is now busy upgrading their forecasts for the year. The higher these go (S&P average forecast operating earnings per share are now at a record high) the less awful valuations look, and the easier it is to justify endlessly rising stockmarkets.
You could also argue that the Federal Reserve, America's central bank, is clearly very conscious of the stockmarket (maybe too conscious) and will be keeping interest rates so low for so long that if you want an income of any kind, there is no alternative to the stockmarket. You might also note that companies must be feeling pretty optimistic: stock issuance is currently at its highest level ever in the US – “blowing away the last high set in the run up to the Tech Bubble”, say the analysts at asset manager GMO. And this isn’t just about new firms coming to market (the Spacs – special purpose acquisition companies – you have heard so much about). Instead, most new issuance is coming from “seasoned companies”.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Unfortunately, none of these things are quite enough. Analysts have a trying tendency to extrapolate everything – basing forecasts not on actual predictions of the future, but on assumptions that the future will be almost identical to the immediate past. Yardeni Research notes that the average analyst’s estimate of forward earnings for US energy companies is up by 1,558% since last year’s lockdown lows. In lockdown, analysts assumed lockdown forever. Out of lockdown they perhaps assume pent-up demand release forever. The latter is as unlikely now as the former was then. As for issuance, it would be nice to think that it reflected companies being full of brilliant ideas as to productive ways to use the cash. However, it is just as likely, as GMO says, to reflect that “Wall Street knows an eager, price-insensitive buyer when it sees one... when the ducks are quacking, it’s time to feed ’em”.
And interest rates? It makes some sense to think about markets in relative terms, but at some point absolutes will matter too. When that happens, eager, price-insensitive buyers will be in for a shock. With that in mind, let us bore you again with the suggestion that you bring some of your cash home – to the UK market. The UK is not as cheap as it was, but it is much cheaper than most other markets. If we don’t buy it, private-equity firms will soon own the lot. And we won’t like that.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Merryn Somerset Webb started her career in Tokyo at public broadcaster NHK before becoming a Japanese equity broker at what was then Warburgs. She went on to work at SBC and UBS without moving from her desk in Kamiyacho (it was the age of mergers).
After five years in Japan she returned to work in the UK at Paribas. This soon became BNP Paribas. Again, no desk move was required. On leaving the City, Merryn helped The Week magazine with its City pages before becoming the launch editor of MoneyWeek in 2000 and taking on columns first in the Sunday Times and then in 2009 in the Financial Times
Twenty years on, MoneyWeek is the best-selling financial magazine in the UK. Merryn was its Editor in Chief until 2022. She is now a senior columnist at Bloomberg and host of the Merryn Talks Money podcast - but still writes for Moneyweek monthly.
Merryn is also is a non executive director of two investment trusts – BlackRock Throgmorton, and the Murray Income Investment Trust.
-
Could investing in sugar protect you during a downturn?
Sugar has some defensive qualities during economic downturns, but is now the right time to invest in sugar?
By Dan McEvoy
-
Trump’s tariffs: how should the UK respond?
Every right-thinking person knows that free trade is a surer route to the wealth of nations than protectionism. So, what is Trump thinking?
By Stuart Watkins
-
Falling revenues and mounting debt spell trouble for Jumia Technologies
Struggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
By Dr Matthew Partridge
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?
Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
By Dr Matthew Partridge
-
Best of British bargains: cash in on undervalued companies in the UK stock market
Opinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
By Michael Field
-
Building firm Keller presents low debt and ample scope for growth
Geotechnical contractor Keller, which supports vital global infrastructure, boasts rising profits and a cheap valuation
By Dr Mike Tubbs
-
PZ Cussons share price down 75% in last decade – why it's one to watch
Opinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
By Jamie Ward
-
Cash in on the biotech sector with specialist trust BioPharma
Opinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
By Rupert Hargreaves
-
India's stock market decline wipes out $1.3 trillion in market value – can investors stay optimistic?
More than $1 trillion has been wiped off from India's stock market after investors turn to China. Has the emerging-market darling hit rock bottom?
By Alex Rankine
-
Pensions revolution: how to profit from the trends shaping the UK pension system
The UK pension system is one of the biggest in the world. Big changes are under way, says Rupert Hargreaves
By Rupert Hargreaves